chrX-56565334-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP7BS2

The NM_013444.4(UBQLN2):​c.1461C>T​(p.Thr487Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,208,016 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. T487T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000010 ( 0 hom. 4 hem. )

Consequence

UBQLN2
NM_013444.4 synonymous

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.79

Publications

3 publications found
Variant links:
Genes affected
UBQLN2 (HGNC:12509): (ubiquilin 2) This gene encodes an ubiquitin-like protein (ubiquilin) that shares high degree of similarity with related products in yeast, rat and frog. Ubiquilins contain a N-terminal ubiquitin-like domain and a C-terminal ubiquitin-associated domain. They physically associate with both proteasomes and ubiquitin ligases; and thus, are thought to functionally link the ubiquitination machinery to the proteasome to affect in vivo protein degradation. This ubiquilin has also been shown to bind the ATPase domain of the Hsp70-like Stch protein. [provided by RefSeq, Oct 2009]
UBQLN2 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 15
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP7
Synonymous conserved (PhyloP=-2.79 with no splicing effect.
BS2
High AC in GnomAdExome4 at 11 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UBQLN2NM_013444.4 linkc.1461C>T p.Thr487Thr synonymous_variant Exon 1 of 1 ENST00000338222.7 NP_038472.2 Q9UHD9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UBQLN2ENST00000338222.7 linkc.1461C>T p.Thr487Thr synonymous_variant Exon 1 of 1 6 NM_013444.4 ENSP00000345195.5 Q9UHD9

Frequencies

GnomAD3 genomes
AF:
0.0000356
AC:
4
AN:
112340
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000282
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000100
AC:
11
AN:
1095623
Hom.:
0
Cov.:
32
AF XY:
0.0000111
AC XY:
4
AN XY:
361227
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26350
American (AMR)
AF:
0.00
AC:
0
AN:
34911
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19336
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30106
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53763
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40314
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4123
European-Non Finnish (NFE)
AF:
0.0000119
AC:
10
AN:
840730
Other (OTH)
AF:
0.0000217
AC:
1
AN:
45990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000356
AC:
4
AN:
112393
Hom.:
0
Cov.:
23
AF XY:
0.0000579
AC XY:
2
AN XY:
34559
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30985
American (AMR)
AF:
0.00
AC:
0
AN:
10732
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2656
East Asian (EAS)
AF:
0.000283
AC:
1
AN:
3536
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2756
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6153
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53135
Other (OTH)
AF:
0.00
AC:
0
AN:
1536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
41
Bravo
AF:
0.0000151

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
1.9
DANN
Benign
0.72
PhyloP100
-2.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45559331; hg19: chrX-56591767; API